Table 3.
Comparison of efficacy of medicament in the elimination of microbes after 3, 6, and 9 weeks of placement of medicament and clinical and radiological signs after 3 and 6 weeks of placement of medicament between TAP group and DAP group using Chi-square test
| At 9 weeks | At 6 weeks | At 3 weeks | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Nil | Group IV streptococci | Coagulase-negative staphylococci | Candida | Nil | S. aureus | Nil | |||||||||
| N | % | N | % | N | % | N | % | p value | N | % | N | % | p value | N | % | |
| TAP N = 10 |
6 | 60 | 2 | 20 | 1 | 10 | 1 | 10 | 0.407 | 10 | 100 | 0 | 0 | 0.908 | 10 | 100 |
| DAP N = 8 |
6 | 75 | 2 | 25 | 0 | 0 | 0 | 0 | 7 | 87.5 | 1 | 12.5 | 8 | 100 | ||
| Clinical signs at 3 weeks | Radiological signs at 3 weeks | Radiological signs at 6 weeks | ||||||||||||||
| Yes | No | Yes | No | Yes | No | |||||||||||
| Group | N | % | N | % | N | % | N | % | N | % | N | % | ||||
| TAP N = 10 0 | 0 | 10 | 100 | 2 | 20 | 8 | 80 | 0.769 | 0 | 0 | 10 | 100 | ||||
| DAP N = 8 0 | 0 | 8 | 100 | 3 | 37. | 5 | 62.5 | 0 | 0 | 8 | 100 | |||||